Nucleic Acids Research, 1984, Vol. 12, No. 20 7787-7792
© 1984
Articles |
Reversion to neurovirulence of the live-attenuated Sabin type 3 oral pollovirus vaccine
Department of Microbiology, Medical Sciences Building, University of Leicester University Road, Leicester LE3 7RH *National Institute for Biological Standards and Control Holly Hill, Hampstead, London NW3 6RB, UK
Received August 29, 1984. Revised October 2, 1984. Accepted October 2, 1984.
The complete nucleotide sequence has been determined of a strain of poliovirus type 3, P3/119, isolated from the central nervous system of a victim of fatal vaccine-associated poliomyelitis. Comparison of this sequence with those obtained previously for the Sabin type 3 vaccine, P3/Leon 12a1 b and its neurovirulent progenitor, P3/Leon/37, reveals that these three strains are on a direct geneaological lineage and therefore that P3/119 is a bona fide revertant of the vaccine. P3/119 differs in sequence from its attenuated vaccine parent at just seven positions. Only one of these differences, a mutation from U to C at position 472 in the presumed noncoding region of the genome, is a back mutation to the wild type sequence. Of the six other differences, three give rise to coding changes in virus structural proteins, two are silent changes in the major open reading frame of the genome and one affects the 3'-terminus just prior to the poly A tract. These differences indicate that there are three possible types of molecular change which could, singly or collectively, result in attenuation and reversion to neurovirulence of the Sabin type 3 vaccine.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Laassri, E. Dragunsky, J. Enterline, T. Eremeeva, O. Ivanova, K. Lottenbach, R. Belshe, and K. Chumakov Genomic Analysis of Vaccine-Derived Poliovirus Strains in Stool Specimens by Combination of Full-Length PCR and Oligonucleotide Microarray Hybridization J. Clin. Microbiol., June 1, 2005; 43(6): 2886 - 2894. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Guest, E. Pilipenko, K. Sharma, K. Chumakov, and R. P. Roos Molecular Mechanisms of Attenuation of the Sabin Strain of Poliovirus Type 3 J. Virol., October 15, 2004; 78(20): 11097 - 11107. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Arita, H. Shimizu, and T. Miyamura Characterization of in vitro and in vivo phenotypes of poliovirus type 1 mutants with reduced viral protein synthesis activity J. Gen. Virol., July 1, 2004; 85(7): 1933 - 1944. [Abstract] [Full Text] [PDF] |
||||
![]() |
R J M Lane, B A Soteriou, H Zhang, and L C Archard Enterovirus related metabolic myopathy: a postviral fatigue syndrome J. Neurol. Neurosurg. Psychiatry, October 1, 2003; 74(10): 1382 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y Li, T Peng, Y Yang, C Niu, L C Archard, and H Zhang High prevalence of enteroviral genomic sequences in myocardium from cases of endemic cardiomyopathy (Keshan disease) in China Heart, June 1, 2000; 83(6): 696 - 701. [Abstract] [Full Text] |
||||
![]() |
P. Muir, U. Kammerer, K. Korn, M. N. Mulders, T. Poyry, B. Weissbrich, R. Kandolf, G. M. Cleator, and A. M. van Loon Molecular Typing of Enteroviruses: Current Status and Future Requirements Clin. Microbiol. Rev., January 1, 1998; 11(1): 202 - 227. [Abstract] [Full Text] [PDF] |
||||





